NDC 13107-319 – Clorazepate Dipotassium

Clorazepate Dipotassium 3.75 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CIV

Product NDC13107-319

Product details

Brand name
Clorazepate Dipotassium
Generic name
Clorazepate Dipotassium
Labeler
Aurolife Pharma LLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA071858
Marketed since
July 17, 1987
Marketing end
February 28, 2027
Pharmacologic class
Benzodiazepine

Active ingredients

Uses, dosage, side effects and warnings for Clorazepate Dipotassium →

Package NDC codes (2)

Package NDCDescriptionSince
13107-319-01100 TABLET in 1 BOTTLE (13107-319-01)Jul 17, 1987
13107-319-05500 TABLET in 1 BOTTLE, PLASTIC (13107-319-05)Jul 17, 1987

Other Clorazepate Dipotassium products